Liu, J. et al. 2025. Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy. Translation: The University of Toledo Journal of Medical Sciences. 13, S3 (Jun. 2025). DOI:https://doi.org/10.46570/utjms-2025-1354.